Literature DB >> 7425901

Effect of corticosteroids on cataract formation.

H W Skalka, J T Prchal.   

Abstract

While the cataractogenic effects of corticosteroids are beyond dispute, disagreement exists concerning effects of total dose, intensity of dose, and duration of administration on cataract formation. We studied 106 adult male patients matched for age, race, and socioeconomic status. We compared posterior subcapsular (PSC) cataract formation among those with (39) and without (67) a history of systemic corticosteroid therapy. Difference in incidence of PSC opacities among patients with and without a history of corticosteroid therapy was statistically significant. However, no statistically significant correlation was found between PSC opacities and total steroid dose, weekly dose (intensity), duration of dose, or age of patient. Our findings agree with some recent literature that suggests the most important factor in steroid-induced PSC cataract formation may be variability in individual susceptibility to side effects of corticosteroids. We suggest abandoning the concept of a "safe" dose.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7425901     DOI: 10.1001/archopht.1980.01020040625007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

Review 1.  Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes.

Authors:  Gerald Gartlehner; Richard A Hansen; Shannon S Carson; Kathleen N Lohr
Journal:  Ann Fam Med       Date:  2006 May-Jun       Impact factor: 5.166

2.  Risk factors for cataracts in systemic lupus erythematosus (SLE).

Authors:  Khaled Alderaan; Vuk Sekicki; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2014-09-26       Impact factor: 2.631

3.  The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?

Authors:  G Stojan; M Petri
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-07-27

4.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

5.  Loss of αB-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart.

Authors:  Sanjay Mishra; Shu-Yu Wu; Alexandra W Fuller; Zhen Wang; Kristie L Rose; Kevin L Schey; Hassane S Mchaourab
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

6.  11β-hydroxysteroid dehydrogenases as targets in the treatment of steroid-associated femoral head necrosis using antler extract.

Authors:  Ribusurong Pu; Hao Peng
Journal:  Exp Ther Med       Date:  2017-11-07       Impact factor: 2.447

7.  Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.

Authors:  Uri Soiberman; Siva P Kambhampati; Tony Wu; Manoj K Mishra; Yumin Oh; Rishi Sharma; Jiangxia Wang; Abdul Elah Al Towerki; Samuel Yiu; Walter J Stark; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2017-02-16       Impact factor: 12.479

8.  Prevalence and 11-Year Incidence of Cataract and Cataract Surgery and the Effects of Socio-Demographic and Lifestyle Factors.

Authors:  Petri K M Purola; Janika E Nättinen; Matti U I Ojamo; Harri A Rissanen; Mika Gissler; Seppo V P Koskinen; Hannu M T Uusitalo
Journal:  Clin Ophthalmol       Date:  2022-04-20

Review 9.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

10.  Cataractogenesis after Repeat Laser in situ Keratomileusis.

Authors:  Ahmad M Mansour; Marwan Ghabra
Journal:  Case Rep Ophthalmol       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.